Anixa Biosciences (ANIX) Short Interest Ratio & Short Volume → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free ANIX Stock Alerts $3.00 +0.13 (+4.53%) (As of 05/10/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Anixa Biosciences Short Interest DataCurrent Short Volume632,100 sharesPrevious Short Volume553,100 sharesChange Vs. Previous Month+14.28%Dollar Volume Sold Short$1.88 millionShort Interest Ratio / Days to Cover5.3Last Record DateApril 30, 2024Outstanding Shares31,900,000 sharesFloat Size30,390,000 sharesShort Percent of Float2.08%Today's Trading Volume117,116 sharesAverage Trading Volume107,820 sharesToday's Volume Vs. Average109% Short Selling Anixa Biosciences ? Sign up to receive the latest short interest report for Anixa Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatANIX Short Interest Over TimeANIX Days to Cover Over TimeANIX Percentage of Float Shorted Over Time Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… Anixa Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024632,100 shares $1.88 million +14.3%2.1%5.3 $2.97 4/15/2024553,100 shares $1.75 million -4.0%1.8%4.6 $3.16 3/31/2024575,900 shares $1.80 million -3.6%1.9%4 $3.12 3/15/2024597,200 shares $2.20 million -3.4%2.0%3.9 $3.69 2/29/2024618,200 shares $2.16 million +8.2%2.1%2.9 $3.50 2/15/2024571,500 shares $2.33 million -16.1%1.9%2.7 $4.08 Get the Latest News and Ratings for ANIX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Anixa Biosciences and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024681,500 shares $3.09 million +1.6%2.3%3.4 $4.54 1/15/2024670,900 shares $2.95 million +10.7%2.2%3.7 $4.39 12/31/2023606,100 shares $2.35 million -8.4%2.1%3.9 $3.88 12/15/2023661,500 shares $2.48 million +14.2%2.2%4.7 $3.75 11/30/2023579,200 shares $1.93 million -1.6%2.0%5 $3.34 11/15/2023588,400 shares $1.69 million -1.2%2.0%12.7 $2.88 10/31/2023595,500 shares $1.88 million -7.7%2.0%12.7 $3.16 10/15/2023645,300 shares $2.16 million +6.1%2.2%12.4 $3.34 9/30/2023608,100 shares $1.99 million -6.0%2.1%7.7 $3.27 9/15/2023647,000 shares $2.12 million +3.3%2.2%8.3 $3.28 8/31/2023626,500 shares $2.30 million -4.0%2.1%8.1 $3.67 8/15/2023652,600 shares $2.41 million -1.6%2.2%8 $3.69 7/31/2023663,000 shares $2.38 million -6.0%2.3%7.5 $3.59 7/15/2023705,300 shares $2.57 million +15.2%2.4%7.4 $3.64 6/30/2023612,400 shares $1.96 million +0.7%2.1%5.7 $3.20 6/15/2023608,400 shares $2.07 million -3.6%2.1%6.6 $3.41 5/31/2023630,800 shares $1.93 million +0.9%2.1%6.5 $3.06 5/15/2023624,900 shares $2.16 million +4.2%2.1%6.3 $3.45 4/30/2023599,500 shares $2.45 million +2.3%2.0%6.4 $4.08 4/15/2023586,200 shares $3.50 million +6.9%2.0%7.3 $5.97 3/31/2023548,300 shares $2.36 million +1.2%1.9%9.5 $4.30 3/15/2023541,600 shares $2.26 million -5.6%1.8%10.2 $4.18 2/28/2023573,600 shares $2.54 million -3.1%1.9%12.2 $4.42 2/15/2023592,000 shares $2.46 million +0.8%2.0%13.6 $4.16 1/31/2023587,300 shares $2.57 million -1.1%2.0%13.2 $4.37 1/15/2023594,000 shares $2.97 million +0.2%2.0%11.9 $5.00 12/30/2022592,700 shares $2.52 million -1.9%2.0%11.7 $4.25 12/15/2022604,400 shares $2.51 million -2.0%2.1%8.7 $4.15 11/30/2022616,600 shares $3.11 million -1.0%2.1%6.8 $5.04 11/15/2022622,500 shares $3.12 million -3.1%2.1%6.8 $5.01 10/31/2022642,600 shares $3.60 million -1.3%2.2%6.8 $5.60 10/15/2022650,800 shares $3.14 million +23.9%2.2%7 $4.82 9/30/2022525,400 shares $2.58 million +15.0%1.8%5.5 $4.92 9/15/2022457,000 shares $2.05 million -2.2%1.6%5.5 $4.48Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (Ad)If you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)Watch my video for all of the details ANIX Short Interest - Frequently Asked Questions What is Anixa Biosciences' current short interest? Short interest is the volume of Anixa Biosciences shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 632,100 shares of ANIX short. 2.08% of Anixa Biosciences' shares are currently sold short. Learn More on Anixa Biosciences' current short interest. What is a good short interest ratio for Anixa Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ANIX shares currently have a short interest ratio of 5.0. Learn More on Anixa Biosciences's short interest ratio. Which institutional investors are shorting Anixa Biosciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Anixa Biosciences: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Anixa Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.08% of Anixa Biosciences' floating shares are currently sold short. Is Anixa Biosciences' short interest increasing or decreasing? Anixa Biosciences saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 632,100 shares, an increase of 14.3% from the previous total of 553,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Anixa Biosciences' float size? Anixa Biosciences currently has issued a total of 31,900,000 shares. Some of Anixa Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Anixa Biosciences currently has a public float of 30,390,000 shares. How does Anixa Biosciences' short interest compare to its competitors? 2.08% of Anixa Biosciences' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Anixa Biosciences: Milestone Pharmaceuticals Inc. (0.81%), ProPhase Labs, Inc. (1.88%), Aclaris Therapeutics, Inc. (8.35%), Eton Pharmaceuticals, Inc. (0.36%), Clearside Biomedical, Inc. (0.45%), Oncolytics Biotech Inc. (1.14%), Spero Therapeutics, Inc. (0.87%), Chimerix, Inc. (1.71%), Oramed Pharmaceuticals Inc. (0.80%), Barinthus Biotherapeutics plc (0.05%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Anixa Biosciences stock? Short selling ANIX is an investing strategy that aims to generate trading profit from Anixa Biosciences as its price is falling. ANIX shares are trading up $0.13 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Anixa Biosciences? A short squeeze for Anixa Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ANIX, which in turn drives the price of the stock up even further. How often is Anixa Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ANIX, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: MIST Short Squeeze PRPH Short Squeeze ACRS Short Squeeze ETON Short Squeeze CLSD Short Squeeze ONCY Short Squeeze SPRO Short Squeeze CMRX Short Squeeze ORMP Short Squeeze BRNS Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ANIX) was last updated on 5/12/2024 by MarketBeat.com Staff From Our PartnersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeCollapse of the Petrodollar Colonial MetalsShocking: One AI startup's revenue could surge 4,735%Manward Press[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICHe Is Giving Away BitcoinCrypto Swap ProfitsMissed NVDA? Buy this AI stock NOWChaikin Analytics